You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 020369

✉ Email this page to a colleague

NDA 020369 describes CILOXAN, which is a drug marketed by Sandoz and is included in two NDAs. It is available from eight suppliers. Additional details are available on the CILOXAN profile page.

The generic ingredient in CILOXAN is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.

Summary for 020369

Tradename:	CILOXAN
Applicant:	Sandoz
Ingredient:	ciprofloxacin hydrochloride
Patents:	0

Pharmacology for NDA: 020369

Mechanism of Action	Cytochrome P450 1A2 Inhibitors

Suppliers and Packaging for NDA: 020369

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CILOXAN	ciprofloxacin hydrochloride	OINTMENT;OPHTHALMIC	020369	NDA	Sandoz Inc	66758-071	66758-071-38	3.5 g in 1 TUBE (66758-071-38)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	OINTMENT;OPHTHALMIC			Strength	EQ 0.3% BASE
Approval Date:	Mar 30, 1998	TE:		RLD:	Yes

Expired US Patents for NDA 020369

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sandoz	CILOXAN	ciprofloxacin hydrochloride	OINTMENT;OPHTHALMIC	020369-001	Mar 30, 1998	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.